About
Research areas
Members
Scientific production
Web Links
Contact
PDC analyzer & database
PaREx:
P. aeruginosa
explorer
fernando
In vitro evolution of cefepime/zidebactam (WCK 5222) resistance in Pseudomonas aeruginosa: dynamics, mechanisms, fitness trade-off and impact on in vivo efficacy
By
fernando
|
20
Apr, 23
|
0 Comments
|
Isabel Barceló 1, Gabriel Cabot 1, Snehal Palwe 2, Prashant…
Comparative analysis of in vitro dynamics and mechanisms of ceftolozane/tazobactam and imipenem/relebactam resistance development in Pseudomonas aeruginosa XDR high-risk clones
By
fernando
|
20
Apr, 23
|
0 Comments
|
María A Gomis-Font 1, 2, Gabriel Cabot 1, 2, Silvia…
A Genomic Snapshot of the SARS-CoV-2 Pandemic in the Balearic Islands
By
fernando
|
20
Apr, 23
|
0 Comments
|
Carla López-Causapé 1, 2, Pablo A Fraile-Ribot 1, 2, Santiago…
Whole-genome sequence-guided PCR for the rapid identification of the Pseudomonas aeruginosa ST175 high-risk clone directly from clinical samples
By
fernando
|
20
Apr, 23
|
0 Comments
|
Gabriel Cabot 1, Paula Lara-Esbrí 1, Xavier Mulet 1, Antonio…
Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and Isogenic β-Lactam-Resistant Mutants
By
fernando
|
20
Apr, 23
|
0 Comments
|
Pablo A Fraile-Ribot 1, Laura Zamorano 1, Rocío Orellana 1,…
Effective inhibition of PBPs by cefepime and zidebactam in the presence of VIM-1 drives potent bactericidal activity against MBL-expressing Pseudomonas aeruginosa
By
fernando
|
20
Apr, 23
|
0 Comments
|
Bartolome Moya 1, Sachin Bhagwat 2, Gabriel Cabot 1, German…
Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections
By
fernando
|
20
Apr, 23
|
0 Comments
|
Gabriel Torrens 1, María Escobar-Salom 1, Elisabet Pol-Pol 1, Cristina…
Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins
By
fernando
|
20
Apr, 23
|
0 Comments
|
Gabriel Torrens 1, Isabel M Barceló 1, Marcelo Pérez-Gallego 1,…
In Vitro and In Vivo Activities of β-Lactams in Combination with the Novel β-Lactam Enhancers Zidebactam and WCK 5153 against Multidrug-Resistant Metallo-β-Lactamase-Producing Klebsiella pneumoniae
By
fernando
|
20
Apr, 23
|
0 Comments
|
Bartolome Moya 1, Isabel M Barcelo 2, Gabriel Cabot 2,…
Biochemical Insights into Imipenem Collateral Susceptibility Driven by ampC Mutations Conferring Ceftolozane/Tazobactam Resistance in Pseudomonas aeruginosa
By
fernando
|
19
Apr, 23
|
0 Comments
|
Gabriel Cabot 1, Kihun Kim 2, Brian L. Mark 2,…
Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa
By
fernando
|
18
Oct, 22
|
0 Comments
|
Isabel M Barceló# 1 2 3, Elena Jordana-Lluch# 1 2,…
Regulation of AmpC-Driven β-Lactam Resistance in
Pseudomonas aeruginosa
: Different Pathways, Different Signaling
By
fernando
|
4
Dec, 19
|
0 Comments
|
Gabriel Torrensa, Sara Belén Hernándezb, Juan Alfonso Ayalac, Bartolome Moyaa,…
Association between
Pseudomonas aeruginosa
O-antigen serotypes, resistance profiles and high-risk clones: results from a Spanish nationwide survey.
By
fernando
|
29
Aug, 19
|
0 Comments
|
Del Barrio-Tofiño E1, Sánchez-Diener I1, Zamorano L1, Cortes-Lara S1, López-Causapé…
Weighting the impact of virulence on the outcome of
Pseudomonas aeruginosa
bloodstream infections.
By
fernando
|
1
Aug, 19
|
0 Comments
|
Sánchez-Diener I1, Zamorano L2, Peña C3, Ocampo-Sosa A4, Cabot G1,…
Spanish nationwide survey on
Pseudomonas aeruginosa
antimicrobial resistance mechanisms and epidemiology.
By
fernando
|
19
Jul, 19
|
0 Comments
|
Del Barrio-Tofiño E1, Zamorano L1, Cortés-Lara S1, Sánchez-Diener I1, Cabot…
Pseudomonas
Conference Attendance
By
fernando
|
21
Jun, 19
|
0 Comments
|
We will be attending to the Pseudomonas International Biennal Conference…
29th ECCMID Digital Poster Versions
By
fernando
|
16
Apr, 19
|
0 Comments
|
Here you can find our work we presented in 29th…
29th ECCMID Attendance
By
fernando
|
10
Apr, 19
|
0 Comments
|
We will be attending to the 29th European Congress of…
O-antigen serotyping and MALDI-TOF, potentially useful tools for optimizing semi-empiric antipseudomonal treatments through the early detection of high-risk clones.
By
fernando
|
7
Feb, 19
|
0 Comments
|
Mulet X1, García R1, Gayá M1, and Oliver A1 1Hospital…
V IdISBa Sessions – V Jornadas IdISBa
By
fernando
|
29
Nov, 18
|
0 Comments
|
We are attending to the V Jornades Institut d'Investigació Sanitària…
Previous
1
…
10
11
12
13
Next